Eos Management LP’s Optimum Communications Inc OPTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.3K Hold
58,800
0.03% 35
2026
Q1
$76.4K Hold
58,800
0.03% 41
2025
Q4
$97K Hold
58,800
0.04% 43
2025
Q3
$142K Hold
58,800
0.06% 43
2025
Q2
$126K Hold
58,800
0.05% 38
2025
Q1
$156K Hold
58,800
0.07% 40
2024
Q4
$142K Hold
58,800
0.06% 40
2024
Q3
$145K Hold
58,800
0.05% 43
2024
Q2
$120K Hold
58,800
0.05% 42
2024
Q1
$153K Hold
58,800
0.06% 41
2023
Q4
$191K Hold
58,800
0.08% 39
2023
Q3
$192K Hold
58,800
0.09% 43
2023
Q2
$178K Hold
58,800
0.08% 42
2023
Q1
$201K Hold
58,800
0.11% 53
2022
Q4
$270K Hold
58,800
0.14% 49
2022
Q3
$343K Sell
58,800
-112,707
-66% -$1.08M 0.36% 22
2022
Q2
$1.59M Hold
171,507
1.21% 13
2022
Q1
$2.14M Hold
171,507
1.26% 12
2021
Q4
$2.77M Buy
171,507
+112,707
+192% +$1.91M 1.63% 9
2021
Q3
$1.22M Buy
+58,800
New +$1.71M 0.76% 17

Other funds holding OPTU

Eos Management LP's OPTU Position: Q2 2026 in Review

Eos Management LP held its Optimum Communications Inc (OPTU) position steady in Q2 2026 at 58,800 shares worth $85.3K. The position accounts for 0.03% of the portfolio, ranked #35.

Eos Management LP first reported a position in OPTU in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.77M in Q4 2021. 193 funds tracked by Wall St. Rank hold OPTU as of Q2 2026.

  • Eos Management LP held 58,800 shares of Optimum Communications Inc worth $85.3K as of Q2 2026.
  • Eos Management LP left its Optimum Communications Inc share count unchanged in Q2 2026.
  • Optimum Communications Inc made up 0.03% of Eos Management LP's portfolio in Q2 2026, its #35 holding.
  • Eos Management LP first reported a position in Optimum Communications Inc in Q3 2021 and has held it in 20 quarters since.
  • Eos Management LP's Optimum Communications Inc position peaked at $2.77M in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Optimum Communications Inc as of Q2 2026.

Based on Eos Management LP's 13F filing for Q2 2026, filed 30 Jul 2026.